Clinical trial
Prophylactic Treatment of Peginterferon-associated Psychopathology. A Double-blind Placebo-controlled Trial on the Effects of Escitalopram (Lexapro®) in Patients Treated With Peginterferon and Ribavirin (POPS Study)
NCT00133276 is registered in ClinicalTrials.gov with Foundation for Liver Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prophylactic Treatment of Peginterferon-associated Psychopathology. A Double-blind Placebo-controlled Trial on the Effects of Escitalopram (Lexapro®) in Patients Treated With Peginterferon and Ribavirin (POPS Study)
- Lead sponsor
- Foundation for Liver Research
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- August 31, 2005
- Completion date
- December 31, 2009
- Enrollment
- 80 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.